Centre Hospitalier Universitaire d'Angers

Futó vizsgálatok

• Toboroz

  Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma

  NCT06485908· 1/2. fázis· Assistance Publique Hopitaux De Marseille· Forrás

• Még nem toboroz

  Efanesoctocog Prophylaxis Or The Optimization Of Treatment: Real-World Experience Of Taylorizing Clotting Therapy In Hemophilia A

  NCT07830693· Nantes University Hospital· Forrás

• Még nem toboroz

  Real World Positioning of Tyrosine Kinase Inhibitors (TKIs) Within Systemic Treatment Strategies for Advanced Neuroendocrine Tumors (NETs)

  NCT07890012· Hospices Civils de Lyon· Forrás

• Még nem toboroz

  Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations

  NCT07738887· 2. fázis· The Lymphoma Academic Research Organisation· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  Analysis of histological risk factors and biomarkers in paediatric retinoblastoma

  2024-515962-15-00· 2. fázis· Institut Curie· Forrás

• Még nem toboroz

  A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma

  NCT07612787· 1/2. fázis· Centre Hospitalier Universitaire de Saint Etienne· Forrás

• Még nem toboroz

  Evaluation of the Effect of Time of Administration on the Activity on First Line of Pembrolizumab in Association With Carboplatin-pemetrexed in Metastatic Non-squamous Lung Cancer. A Randomised Multicenter Phase III Trial

  NCT07915037· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Prognostic and Predictive Factors in Childhood Soft Tissue Sarcomas

  NCT07924384· Institut Curie· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3

  2026-526408-60-00· 2. fázis· Vico Therapeutics B.V.· Forrás

• Még nem toboroz

  Discontinuation Versus Continuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary Hypertension Successfully Treated With Balloon Pulmonary Angioplasty

  NCT07644377· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France

  NCT07851844· Assistance Publique - Hôpitaux de Paris· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Még nem toboroz

  A Study to Investigate the Effects of Cleminorexton Compared with Placebo in the Treatment of Participants with Central Disorders of Hypersomnolence

  2026-525961-37-00· 2/3. fázis· Centessa Pharmaceuticals UK Limited· Forrás

• Még nem toboroz

  ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.

  NCT07737964· 3. fázis· University Hospital, Montpellier· Forrás

• Toboroz

  Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

  NCT07441200· 2. fázis· NS Pharma, Inc.· Forrás

• Toboroz

  A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  2025-525016-41-00· 2. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

  NCT07721363· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).

  NCT07624799· 2. fázis· French Innovative Leukemia Organisation· Forrás

• Még nem toboroz

  OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.

  2025-524003-68-00· 2. fázis· Assistance Publique Hopitaux De Paris· Forrás

• Még nem toboroz

  Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy

  NCT07547033· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer

  NCT07828938· Fondation Hôpital Saint-Joseph· Forrás

• Még nem toboroz

  Prospective evaluation of response to treatment by analysis of measurable residual disease in younger adult patients (18-60 years) with acute myeloid leukemia (AML). The Backbone InterGroup (BIG)-2 umbrella trial from the Acute Leukemia French Intergroup (ALFA, FILO) - BIG2

  2026-525759-96-00· 4. fázis· Centre Hospitalier Universitaire De Toulouse· Forrás

• Toboroz

  International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

  NCT07476729· 3. fázis· Charite University, Berlin, Germany· Forrás

• Még nem toboroz

  Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.

  NCT07463768· 2. fázis· French Innovative Leukemia Organisation· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)

  2023-505575-69-01· 3. fázis· Institut Gustave Roussy· Forrás

• Toboroz

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  NCT07621809· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Prilenia· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

  NCT07581002· 2/3. fázis· AbbVie· Forrás

• Toboroz

  Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

  NCT07463963· Poitiers University Hospital· Forrás

• Toboroz

  Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07284602· 3. fázis· PureTech· Forrás

• Toboroz

  ETCABio - Evaluation of Skin Tests in Biotherapy Allergies

  2024-519812-15-00· 4. fázis· Centre Hospitalier Universitaire D'Angers· Forrás

• Toboroz

  Evaluation of Skin Tests in Biotherapy Allergies

  NCT06971848· University Hospital, Angers· Forrás

• Toboroz

  Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

  NCT07378072· Nantes University Hospital· Forrás

• Még nem toboroz

  A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

  2024-516570-30-00· 2. fázis· Centre Hospitalier De Versailles· Forrás

• Még nem toboroz

  Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial

  NCT07497750· University Hospital, Toulouse· Forrás

• Toboroz

  A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  NCT07357727· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

  NCT07429266· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás

• Toboroz

  A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

  NCT07393282· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)

  2025-524160-38-00· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Cohort of Patients With Chronic Myelomonocytic Leukemia

  NCT07512882· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Toboroz

  COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities

  NCT07245680· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Toboroz

  A Phase 3 Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children with Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

  2025-523079-44-00· 3. fázis· Ascendis Pharma Endocrinology Division A/S· Forrás

• Toboroz

  A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

  NCT07203053· 2. fázis· ETOP IBCSG Partners Foundation· Forrás

• Toboroz

  A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

  NCT07489495· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma

  2024-519208-29-00· 2. fázis· Intergroupe Francophone De Cancerologie Thoracique· Forrás

• Toboroz

  Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma

  NCT07234058· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Még nem toboroz

  Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease

  NCT07409597· University Hospital, Angers· Forrás

Showing 50 of 339.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok36 toboroz
• Tüdőrák23 toboroz
• Akut mieloid leukémia (AML)19 toboroz
• Mieloproliferatív neopláziák10 toboroz
• Zsírmáj (MASLD/MASH)10 toboroz
• Akut limfoid leukémia (ALL)9 toboroz
• Krónikus limfoid leukémia (CLL)9 toboroz
• Mielóma multiplex9 toboroz
• Huntington-kór7 toboroz
• Idiopátiás tüdőfibrózis7 toboroz
• Máj- és epeúti rák7 toboroz
• Mielodiszplasztikus szindróma (MDS)7 toboroz
• Vesedaganat7 toboroz
• Elhízás6 toboroz
• Magas vérnyomás6 toboroz
• Neuroendokrin daganatok6 toboroz
• Hasnyálmirigyrák5 toboroz
• Szívelégtelenség5 toboroz
• Follikuláris limfóma4 toboroz
• Gyomor- és nyelőcsőrák4 toboroz
• Hólyagrák4 toboroz
• Mezotelióma4 toboroz
• Pulmonális artériás hipertónia4 toboroz
• Stroke (szélütés)4 toboroz
• Vastagbélrák4 toboroz
• Amiloidózis3 toboroz
• Liver cirrhosis3 toboroz
• Szarkóma3 toboroz
• Szisztémás szklerózis (szkleroderma)3 toboroz
• Amiotrófiás laterálszklerózis (ALS)2 toboroz
• ANCA-asszociált vasculitis2 toboroz
• Aplastic anaemia2 toboroz
• Asztma2 toboroz
• Brain aneurysm2 toboroz
• Bronchiectasis2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Epilepszia2 toboroz
• Fej-nyaki daganatok2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
• Krónikus mieloid leukémia (CML)2 toboroz
• Krónikus vesebetegség2 toboroz
• Lupus (SLE)2 toboroz
• Melanóma2 toboroz
• Obstructive sleep apnoea2 toboroz
• Petefészekrák2 toboroz
• Pitvarfibrilláció2 toboroz
• Sjögren-szindróma2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Aortic stenosis1 toboroz
• Cerebral palsy1 toboroz
• Charcot-Marie-Tooth disease1 toboroz
• Cisztás fibrózis1 toboroz
• Congenital heart disease1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Glioblasztóma1 toboroz
• Hemofília1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• HIV-fertőzés1 toboroz
• Hodgkin-limfóma1 toboroz
• Immune thrombocytopenia (ITP)1 toboroz
• Insomnia1 toboroz
• Köpenysejtes limfóma1 toboroz
• Koszorúér-betegség1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Myocarditis1 toboroz
• Narcolepsy1 toboroz
• Neuroblasztóma1 toboroz
• Pajzsmirigyrák1 toboroz
• Parkinson-kór1 toboroz
• Peripheral artery disease1 toboroz
• Prosztatarák1 toboroz
• Sarcoidosis1 toboroz
• Turner syndrome1 toboroz

Lezárt vizsgálatok

• Toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

  NCT07596849· 3. fázis· argenx· Forrás

• Toboroz

  Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

  NCT07048262· 2. fázis· CSL Behring· Forrás

• Leállították

  A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

  NCT06987968· 2. fázis· Genfit· Forrás

• Toboroz

  A Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy

  2023-507097-41-01· 3. fázis· Shanghai Junshi Biosciences Co. Ltd.· Forrás

• Lezárult

  A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral TTI-0102 for Treatment of Patients with Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).

  2023-506723-28-00· 2. fázis· Thiogenesis Therapeutics· Forrás

• Fut, nem toboroz

  A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

  NCT06422884· 2. fázis· Endeavor Biomedicines, Inc.· Forrás

• Lezárult

  ALS Phase II Study of NX210c

  NCT06365216· 2. fázis· Axoltis Pharma· Forrás

• Lezárult

  Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants with Major Depressive Disorder

  NCT06029439· 3. fázis· Neumora Therapeutics Inc.· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Boehringer Ingelheim International GmbH· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A clinical study for patients with newly diagnosed, locally advanced non-small cell lung cancer (NSCLC) with a change in the ALK-gene, to test the effect of brigatinib after standard chemotherapy and radiation therapy is completed.

  NCT05718297· 2. fázis· ETOP IBCSG Partners Foundation· Forrás

• Lezárult

  An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

  NCT06179875· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Lezárult

  A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

  NCT06208306· 3. fázis· Sanofi· Forrás

• Lezárult

  Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy

  NCT06054347· University Hospital, Angers· Forrás

• Lezárult

  Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

  NCT06058039· 3. fázis· Neumora Therapeutics, Inc.· Forrás

• Lezárult

  An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

  NCT06021054· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Lezárult

  Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

  NCT05882734· 1/2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  Intubation of Obese Patients in the Operating Room With or Without Face Mask Ventilation

  NCT05930678· Nantes University Hospital· Forrás

• Fut, nem toboroz

  A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

  NCT05785767· 2/3. fázis· Regeneron Pharmaceuticals· Forrás

• Leállították

  CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases

  NCT05546606· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

  NCT03966651· 1. fázis· Institut Claudius Regaud· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI

  NCT05601973· 2. fázis· ETOP IBCSG Partners Foundation· Forrás

• Fut, nem toboroz

  GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

  NCT05686551· 2. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis

  NCT04789850· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  EFFICACY AND SAFETY TRIAL OF EPCORITAMAB WITH OR WITHOUT LENALIDOMIDE AS FIRST LINE THERAPY FOR SUBJECTS WITH DIFFUSE LARGE B-CELL LYMPHOMA.

  2023-504832-16-00· 2. fázis· Genmab A/S· Forrás

• Lezárult

  Phase 2b Study of GSK4532990 in Adults With NASH

  NCT05583344· 2. fázis· GlaxoSmithKline· Forrás

• Lezárult

  Ezurpimtrostat autophagy inhibitor in association with Atezolizumab-Bevacizumab in first line treatment of unresectable hepatocellular carcinoma, a phase 2b randomized trial. ABE-LIVER

  NCT05448677· 2. fázis· Centre Hospitalier Universitaire De Grenoble· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Bayer AG· Forrás

• Fut, nem toboroz

  A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)

  NCT05490446· 2. fázis· Agios Pharmaceuticals, Inc.· Forrás

• Leállították

  Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

  NCT05516498· 2. fázis· AstraZeneca· Forrás

• Lezárult

  Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

  NCT05322096· 2. fázis· Gedeon Richter Plc.· Forrás

• Fut, nem toboroz

  A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

  NCT05450692· 3. fázis· AstraZeneca· Forrás

• Lezárult

  Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

  NCT05458856· 3. fázis· Ipsen· Forrás

• Fut, nem toboroz

  Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

  NCT05349214· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

  NCT05232071· 2. fázis· Inventiva Pharma· Forrás

• Lezárult

  A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

  NCT05218655· 3. fázis· PTC Therapeutics· Forrás

• Lezárult

  A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)

  NCT05358717· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

  NCT05030155· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  LAMSA2020: “A phase II randomized study to assess the efficacy on outcome of Venetoclax combined with Cytarabine versus Idarubicin combined with Cytarabine administered as post-remission therapy to elderly patients with acute myeloid leukemia in first remission”

  2022-502392-37-00· 2. fázis· French Innovative Leukemia Organization· Forrás

• Lezárult

  A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients.

  NCT04811092· 3. fázis· Acceleron Pharma Inc.· Forrás

• Lezárult

  Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

  NCT05308966· Groupe Francais De Pneumo-Cancerologie· Forrás

• Lezárult

  A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

  NCT05260021· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm

  NCT04992949· 2. fázis· French Innovative Leukemia Organisation· Forrás

• Lezárult

  A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

  NCT04945460· 2. fázis· Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA· Forrás

• Lezárult

  Multicenter Validation of the Salivary miRNA Signature of Endometriosis

  NCT05244668· ZIWIG· Forrás

• Lezárult

  Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

  NCT04890028· Institut Cancerologie de l'Ouest· Forrás

• Lezárult

  PET-DOPA Metabolic Detection and Characterization of Untreated Brain Metastases of Bronchial, Breast and Melanoma Cancer

  2024-515850-26-00· 2. fázis· Institut De Cancerologie De L Ouest· Forrás

• Lezárult

  A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

  NCT04896008· 3. fázis· Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA· Forrás

• Lezárult

  Study of Avelumab in combination with Lenvatinib for children with primary CNS tumors

  NCT05081180· 1. fázis· Merck Healthcare KGaA· Forrás

Showing 50 of 97.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Zsírmáj (MASLD/MASH)22 munka · 20 vizsgálat
• Mielodiszplasztikus szindróma (MDS)9 munka · 21 vizsgálat
• Mieloproliferatív neopláziák9 munka · 26 vizsgálat
• Spinális izomatrófia (SMA)6 munka · 0 vizsgálat
• Aplastic anaemia3 munka · 2 vizsgálat